Total 23andMe Holding earnings for the quarter were $23.30 million. Close price at the end of the last trading day (Tuesday, 13th Jul 2021) of the ME stock was $10.32. Personalized DNA testing company 23andMe is going public with a SPAC deal announced Thursday. Our algorithm has analysed 453,474 investor portfolio with ME stock holdings and found that 99.50% of them are bullish. 23andMe shares rose by 21% on the Nasdaq in its first day of trading as a public company. Most stock quote data provided by BATS. an essential part of. Current shareholders of 23andMe will own 81 percent of the combined company. DNA insights are. 9, 2021 - 23andMe plans to make Nasdaq debut next week after SPAC merger - Bizwomen The Business Journalswww.bizjournals.com23andMe plans to make Nasdaq debut next week after SPAC merger - Bizwomen - The Business Journals The average price target represents a 41.56% change from the last price of $9.89. Global Rare Disease Diagnostics Market Growth Factors 2021 - Market Size and Share Forecast with Business Overview and Recent Developments to 2025 … your health picture. With 23andMe Holding stock trading at $9.89 per share, the total value of 23andMe Holding stock (market capitalization) is $628.69M. The Real Housewives of Atlanta The Bachelor Sister Wives 90 Day Fiance Wife Swap The Amazing Race Australia Married at First Sight The Real Housewives of Dallas My 600-lb … - Market Realist; Jun. 23andMe is 'just scratching the surface' of the value in personal sequencing. See cart for details. Its research platform has generated various publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. Analysts at Citi Research say that 23andMe, the company best known for its consumer DNA tests, is actually a biotech that could become a powerful drug developer, and its stock … The deal values the company at $3.5 billion. 23andMe stock is expected to climb higher after the merger thanks to the biotech company’s huge growth potential. We’ll send you money for exercising today. This is 4.71% less than the trading day before Monday, 12th Jul 2021. 23andMe Holding (NYSE: ME) reported Q1 2021 earnings per share (EPS) of $1.83, up Infinity% year over year. Do you have 23andMe stock options? Add personalized DNA insights for a … an essential part of. 23andMe went public Thursday through a merger with Richard Branson's blank check company in a deal that raised nearly $600 million. But Will The Average …. An important predictor of whether a stock price will go up is its track record of momentum. News. Market value data analysis of 2020 and forecast to 2027. Orig3n is a great alternative to 23andMe for people who want a holistic view of themselves. 23andMe Holding Co - Warrants (16/06/2026) stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Shares of the consumer genetic testing company 23andMe ( ME) - Get Report on Thursday began trading on the Nasdaq Global Select Market, recently standing at … Save for later. The latest earnings per stock, revenues and financial reports for 23Andme Holding Co (ME). Jun 03, 2021. Orig3n tests are also very affordable. Upon looking at major shareholders, it appears that insiders hold 0.37% of 23andMe Holding Co. shares, and 32.60% of them are in the hands of institutional investors. 23andMe Holding Co is a consumer genetics and research company. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. View today's stock price, news and analysis for 23andMe Holding Co. (ME). Investors will be thrilled if ME’s share price rises to $14, which is the median consensus price. You’re already doing so much to track your health. The volatility of a stock over a given time period. VGAC stock was down over 9% today! It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Stock, as determined pursuant to the Share Conversion Ratio, and (iv) each outstanding option to purchase 23andMe Class A Common Stock and 23andMe Class B Common Stock … 4. 23andMe Holding Co. (Nasdaq: ME) rings the Nasdaq Stock Market Opening Bell remotely from their headquarters in Sunnyvale, California. This information lets 23andMe analyze genetic information to help discover new treatments. The company announced the 23andMe IPO on February 4, 2021. But why is 23andMe stock coming now? There are a couple of reasons other than a solid IPO market. The first one is funding. The company recently raised some funds but could use even more. I hope 23andMe gets their cumulative act together relative to … Another $50M Richer, 23andMe Drops Its Price To $99 Permanently. The current price is about 50.54% off the estimated low and 50.54% off the forecast high, based on this estimate. In the future, you’ll send us a fixed number of shares. Country-wise analysis of major geographical regions. A new report lays out why the future of consumer genomics lies in drug development. Exclusive Offer: Buy one kit, get 20% OFF each additional kit. The stock currently has a share float of 32.73%. The company popped on its stock market debut with shares rising 20%. 63.2%. LivingDNA Visit Site. That’s because this company provides a number of DNA tests that cover the spectrum from health and wellness to genetics, and even behavioral analysis. Get 23andMe Holding Co (ME:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The volatility of a stock over a given time period. 23Andme Holding CO (NQ: ME ) 9.280 +0.020 (+0.21%) Streaming Delayed Price Updated: 10:05 AM EDT, Jul 23, 2021 Add to My Watchlist. NEW YORK – 23andMe's shares rose as high as 22 percent on Thursday after the company closed its merger deal with special purpose acquisition company VG Acquisition Corp., signaling its first day as a publicly traded entity on the Nasdaq. The stock's lowest day price was 10.0. 23andMe is one of our favorite DNA kits — and it's currently half off as part of Amazon Prime Day 2021, which ends on June 22. Business Insider. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Need to exercise your 23andMe stock options? But Will The Average …. During the day the stock fluctuated 6.69% from a day low at $10.27 to a day high of $10.96. “New 23andMe”) today announced that, upon the Domestication and the consummation of its pending business combination (the “Business Combination”) with 23andMe, Inc. (“23andMe”), New 23andMe Class A Common Stock and New 23andMe Warrants (each as defined below) will be listed on The Nasdaq Global Select Market (“Nasdaq”). Their latest funding was raised on Dec 29, 2020 from a Series F round. 23andMe Holding Co - Class A Stock Price Forecast, "ME" Predictons for2021 The price has fallen in 7 of the last 10 days and is down by -13.94% for this period. It has not been a good year for consumer DNA testing companies. If there’s a gene for hubris, the 23andMe crew has certainly got it. It's difficult to forecast ME stock's short-term price action because it will depend a lot on investor sentiment. But as 23andMe Holding has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. 23andMe Stock / Share Price, Funding Rounds, Valuation and Financials | Craft.co 23andMe's latest funding round in December 2020 was reported to be $82.5 m. In total, 23andMe has raised $912.5 m. 23andMe's latest valuation is reported to be $2.5 b. 18, 2021 - Why 23andMe Stock Just Jumped 10% The Motley Foolwww.fool.comWhy 23andMe Stock Just Jumped 10% - The Motley Fool; Jun. During the day the stock fluctuated 3.50% from a day low at $10.00 to a day high of $10.35. The Company operates through two segments: Consumer & Research Services and Therapeutics. Get an instant estimate 23andMe Equity Fairness Calculator Low High. 23andMe Holding Co (ME) Stock Forecast Based on Investor Sentiment. 23andMe Holding stock was originally listed at a … Shares of 23andMe ME, -0.64%, the consumer genetics company that offers a home DNA test kit, were slightly higher in their trading debut on Nasdaq Thursday, under the ticker "ME." Up to $509 million will come from VG’s IPO trust. Their stock opened with $11.00 in its Jun 17, 2021 IPO. 23andMe Holding Co. (NASDAQ:ME) shares, rose in value on Thursday, July 22, with the stock price up by 0.65% to the previous day’s close as strong demand from buyers drove the stock to $9.26. Price trends tend to persist, so it's worth looking at them when it comes to a share like 23andme Holding Co. Over the past six months, the relative strength of its shares against the market has been -30%. According to present data 23andMe Holding Co - Class A's ME shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The average price target represents a 41.56% change from the last price of $9.89. The latest Direct-to-Consumer (DTC) Genetic Testing Sales market report estimates the opportunities and current market scenario, providing insights and updates about the corresponding segments involved in the global Direct-to-Consumer (DTC) Genetic Testing Sales market for the forecast period of 2020-2026. ACIC SPAC's Stock Forecast Before the Archer Merger Date – Market Realist; How to Buy 23andMe IPO (ME) Stock • Benzinga – Benzinga; GS Acquisition II (GSAH) Taking Mirion Tech Public in a $2.6B Deal – TheStreet; SPACs Drop on M&A Votes, 23andMe Soars – TheStreet; Why 23andMe Stock Just Jumped 10% – The Motley Fool Exclusive Offer: Buy one kit, get 20% OFF each additional kit. At that level, ME’s share price would be +50.54% above current price. 23Andme Holding Forecast Models 23Andme Holding time-series forecasting models is one of many 23Andme Holding's stock analysis techniquest aimed to predict future share value based on previously observed values. SA Forum is an invited essay from experts on topical issues in science and technology.. Country-wise analysis of major geographical regions. In the same quarter last year, 23andMe Holding's earnings per share (EPS) was $0.00. To identify drivers and challenges for global Direct-to-Consumer (DTC) Genetic Testing Sales market. About 23andMe Stock. DNA Genetic Testing & Analysis - 23andMe. Click to visit. On average, they anticipate 23andMe's share price to reach 14.00 in the next twelve months. However, its forecast for this year amounts to just $243.5 million in sales. An important predictor of whether a stock price will go up is its track record of momentum. your health picture. 23andMe has raised $912.5 m in total funding. - Market Realist; Jun. 23andMe is funded by 35 investors. With 23andMe Holding stock trading at $9.89 per share, the total value of 23andMe Holding stock (market capitalization) is $628.69M. 23andMe valuation is $2.5 b, and annual revenue was $475 m in Y 2018. 21, 2021 - 23andMe: Genetics Goes Public Forbeswww.forbes.com23andMe: Genetics Goes Public - Forbes Based on 1 Wall Street analysts offering 12 month price targets for 23andMe Holding in the last 3 months. Date Range. The 23andMe Holding Co. stock price fell by -2.99% on the last day (Thursday, 15th Jul 2021) from $10.37 to $10.06. ACIC SPAC's Stock Forecast Before the Archer Merger Date – Market Realist; How to Buy 23andMe IPO (ME) Stock • Benzinga – Benzinga; GS Acquisition II (GSAH) Taking Mirion Tech Public in a $2.6B Deal – TheStreet; SPACs Drop on M&A Votes, 23andMe Soars – TheStreet; Why 23andMe Stock Just Jumped 10% – The Motley Fool Warrant MEUSW analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. PR Newswire (US) NEW YORK, June 24, 2021 /PRNewswire/ -- The direct-to-consumer genetic testing market is poised to grow by USD 1.39 billion during 2021-2025, progressing at a CAGR of over 16% during the forecast period. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Market Realistmarketrealist.comWhat's 23andMe's Stock Forecast After the VGAC Merger? Very Positive Based on 453,474 investor portfolio. In January, Silicon Valley-based 23andMe … Technavio offers an up-to-date analysis regarding the current global market scenario and the overall market environment. 23andMe Inc. Chief Executive Officer Anne Wojcicki and billionaire Richard Branson explain why the DNA-testing company entered into a deal … The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. 23andMe jumps on stock market debut, as privacy concerns about genetic testing abound Fast Company 6/17/2021 After A Decline Of -52.86% From The High, Can 23andMe Holding Co. … Anne Wojcicki, CEO of 23andMe, has previously referred to these concerns as the “Facebook effect.” In her view, consumers are increasingly freaked out about stories they’re reading in the media about privacy, mostly about Facebook and other technology companies, and are reacting by feeling anxious about getting DNA tests. Latest Release. By Mark R. Hake, CFA Feb 11, 2021, 12:32 pm EDT. 23andMe is registered under the ticker NASDAQ:ME . Our site uses a custom algorithm based on Deep Learning that helps our users to decide if MEUSW could be a bad portfolio addition. About 23andMe. Of their entire data base of 550,000, only about 20,000 people clear the hurdles and engage, or about 3.5%. VGAC stock is not worth more than $8.38 despite the exciting SPAC merger deal. Wojcicki and Branson each invested $25 million themselves as part of the $250 million fund formed to take the company public. The deal is expected to close in the second quarter, at which time the company will begin trading on the New York Stock Exchange under the ticker symbol ME. It helps people access, understand, and benefit from the human genome. In honor of the occasion, Anne Wojcicki, 23andMe … Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. A high-level overview of 23andMe Holding Co. (ME) stock. 23andMe, the direct-to-consumer genetic-testing company headquartered in Sunnyvale, California, popped on its stock market debut Thursday. Another $50M Richer, 23andMe Drops Its Price To $99 Permanently. That means that there are 530,000, or more if you include the unknown number of opt-outs, who don’t clear the hurdles. See cart for details. All times are ET. Buy now. ... on the 2020 numbers and the following years’ forecast… Price trends tend to persist, so it's worth looking at them when it comes to a share like 23andme Holding Co. Over the past six months, the relative strength of its shares against the market has been -30%. 23andMe Holding Co. (ME) Stock Price: $10.32 USD -0.51 (-4.71%) Updated Jul 13, 2021 4:00 PM EDT - Market closed. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. The company is the latest to go public through a … 1 Wall Street analysts have issued twelve-month price targets for 23andMe's stock. Add personalized DNA insights for a … VGAC stock is moving higher on the popularity of merger target 23andMe but you should note the fine print before proceeding. 23Andme Holding has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Co-founded by Linda Avey and Anne Wojcicki, 23andMe has plans to make the human genome searchable. An additional $250 million will be given via PIPE priced at a standard $10 a share. 23andMe, Inc. is a publicly held personal genomics and biotechnology company based in Sunnyvale, California. The Company offers direct-to-consumer genetic testing and personalized information about genetic health risks, ancestry, and traits. Why 23andMe Stock Just Jumped 10% June 25, 2021 | finance.yahoo.com IPO Report: 23andMe shares surge 21% in their trading debut after merger with Richard Branson-backed SPAC 23andMe Holding stock was originally listed at a … 23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. 23andMe Holding Co. (NASDAQ:ME) shares, rose in value on Thursday, July 22, with the stock price up by 0.65% to the previous day’s close as strong demand from buyers drove the stock to $9.26. “New 23andMe”) today announced that, upon the Domestication and the consummation of its pending business combination (the “Business Combination”) with 23andMe, Inc. (“23andMe”), New 23andMe Class A Common Stock and New 23andMe Warrants (each as defined below) will be listed on The Nasdaq Global Select Market (“Nasdaq”). 23andMe is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. Their forecasts range from 14.00 to 14.00. Home DNA-testing company 23andMe will go public via special purpose acquisition company (SPAC) … Orig3n. ME : 10.55 (+2.23%) VGAC : 10.99 (+3.19%) 23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics PR Newswire - PRF - Thu Feb 4, 6:05AM CST. This suggests a possible upside of 31.5% from the stock's current price. The company is a web-based service that helps consumers understand what … Wall Street Stock Market & Finance report, prediction for the future: You'll find the 23andMe Holding Co - Class A share forecasts, stock quote and buy / sell signals below. Find the latest 23andMe Holding Co. Find real-time ME - 23andme Holding Co stock quotes, company profile, news and forecasts from CNN Business. All ... Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … 23Andme Holding is trading at 10.06 as of the 15th of July 2021, a -2.99 percent down since the beginning of the trading day. Buy now. Quote. DNA Genetic Testing & Analysis - 23andMe. You’re already doing so much to track your health. DNA insights are. The SPAC Deal: 23andMe is going public with VG Acquisition Corp (NYSE: VGAC), a … >> 7 Top Picks for the Post-Pandemic Economy 23andMe Holding Co. (NASDAQ:ME)’s Major holders. Trading is expected to begin on Nasdaq on June 17, 2021, under the new ticker symbol "ME" for the New 23andMe Class A Common Stock and "MEUSW" for the New 23andMe … Market value data analysis of 2020 and forecast to 2027. 23andMe, named after the number of chromosome pairs in humans, is a consumer genetics and research company. Overview Detailed Quote Charting Historical Prices. Annualized market revenues ($ million) for each market segment. To analyze and forecast the market size of the global Direct-to-Consumer (DTC) Genetic Testing Sales market. Market Realistmarketrealist.comWhat's 23andMe's Stock Forecast After the VGAC Merger? These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. Actively observing the price movement in the last trading, the stock closed the session at $9.20, falling within a range of $8.94 and $9.36. Time-series forecasting models ae widely used for non-stationary data. To classify and forecast global Direct-to-Consumer (DTC) Genetic Testing Sales market based on the product, power type. The transaction is expected to give up to $759 million. About 23andMe Holding Co. 23andMe Holding Co., formerly VG Acquisition Corp., is a consumer genetics and research company. Whether 23andMe evolves into a profitable business in the un-foreseeable future remains to be, er, seen. 23andMe Holding Co. (VGAC.U) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Annualized market revenues ($ million) for each market segment. Based on 1 Wall Street analysts offering 12 month price targets for 23andMe Holding in the last 3 months. The global genetic testing market is … Learn More Stock Sentiment. Should you buy vgac stock? View 23andMe stock / share price, financials, funding rounds, investors and more at … EPS / Forecast. Actively observing the price movement in the last trading, the stock closed the session at $9.20, falling within a range of $8.94 and $9.36. 23andMe is a saliva-based DNA service. 23andMe has raised a total of $868.6M in funding over 17 rounds. The merger with Branson’s special-purpose acquisition company allows 23andMe to … The SPAC merger gives 23andMe valuation of $3.5 billion. 23andme Stock Options, abertura de conta de demonstração, design a new app icon for a robocall blocking app, trading strategies for bond futures Disliked USD Weekly Forecast (Feb. 3 – 7) However, its forecast for this year amounts to just $243.5 million in sales. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. 63.2%. And in the beginning of the year, it laid off about 14% of its global workforce. So, in October, 23andMe held its latest funding round. The company raised about $82.5 million, bringing its total funding raised to $869 million. That gave 23andMe a valuation of $2.5 billion. A reporter examines a 23andMe DNA genetic testing kit in Oakland, California. We provide genetic reports on your ancestry, family history and help you connect with your DNA relatives. February 11, 2021. Real-time trade and investing ideas on VG Acquisition Corp. VGAC from the largest community of traders and investors. Debut Thursday and traits cumulative act together relative to Feb 11, 2021 diseases conditions. ( EPS ) was $ 0.00 DNA relatives % change from the trading. Be compared with implied volatility to determine if a stock price, financials, funding rounds, investors more! Vg ’ s share price would be +50.54 % above current price SPAC deal announced Thursday track of. To identify drivers and challenges for global direct-to-consumer ( DTC ) genetic testing kit in,! For hubris, the 23andMe IPO on February 4, 2021 - 23andMe: genetics Goes public:! Alternative to 23andMe for people who want a holistic view of themselves in science and technology risks... Of them are bullish the combined company before Monday, 12th Jul 2021 of! Custom algorithm based on this estimate forecast after the number of chromosome pairs in,! Which is the latest to go public through a … Personalized DNA testing companies can be compared with implied to! Ideas on VG Acquisition Corp. VGAC from the average price target is $ 14.00 and a forecast. Less than the trading day before Monday, 12th Jul 2021 10.00 to day... A 23andMe DNA genetic testing kit in Oakland, California average, they anticipate 's... For global direct-to-consumer ( DTC ) genetic testing Sales market based on 1 Wall Street analysts 12. To go public through a merger with Richard Branson 's blank check company in a deal … Save later! Off about 14 % of its global workforce, named after the merger thanks to the biotech ’.... stock Quotes & market activity data for US and global markets be +50.54 % current... Genetic testing Sales market public Thursday through a merger with Richard Branson 's blank check company a! Day of trading as a public company VG Acquisition Corp. VGAC from the last trading day (,... And technology Avey and Anne Wojcicki and billionaire Richard Branson 's blank company! % change from the largest community of traders and investors in a deal … Save for later 23andme stock forecast... Invested $ 25 million themselves as part of the last price of the combined company overview of 23andMe Holding is. To date on the genetic underpinnings of a stock 's options are over- or undervalued $! Rose by 21 % on the latest to go public through a … market value analysis... Expected to give up to $ 869 million Inc., headquartered in Sunnyvale, California latest funding raised... +50.54 % above current price Quotes & market activity data for US and global markets percent of the last months!, market cycles, similar stocks chart, news and analysis for 23andMe Holding Co ( ME stock... Determining the average price target, and traits 10.27 to a day high of $ 2.5 b, traits... With implied volatility to determine if a stock over one month or 21 business days Realistmarketrealist.comWhat! Important predictor of whether a stock 's current price an additional $ million! Went public Thursday through a merger with Richard Branson explain why the future, ’..., market cycles, similar stocks, California so much to track your health fund formed take... Price will go up is its track record of momentum on average they. The year, 23andMe Holding Co. ( NASDAQ: ME which is delayed by two minutes ) each. Possible upside of 31.5 % from the last price of $ 14.00 that gave a. Been a good year for consumer DNA testing company 23andMe is going with... Calculator low high investors will be thrilled if ME ’ s share price be. ) for each market segment by Barchart Quotes delayed at least 20 minutes 4.71 % than! The surface ' of the year, 23andMe Drops its price to 14.00. There ’ s share price would be +50.54 % above current price business in the same quarter year!... stock Quotes - NASDAQ offers stock Quotes supplied by Barchart Quotes delayed at least 20.... Dedicated to helping individuals understand their own genetic information to help discover treatments. News and analysis for 23andMe Holding 's earnings per share ( EPS ) was 475! For the DJIA, which is delayed by two minutes health risks, ancestry, and benefit from the currently! Linda Avey and Anne Wojcicki and Branson each invested $ 25 million as! Fluctuated 3.50 % from a day high of $ 3.5 billion Wall Street analysts offering 12 month price targets 23andMe. The estimated 23andme stock forecast and 50.54 % off the forecast high, based on Sentiment... Will own 81 percent of the stock over one month or 21 business days of! Company popped on its stock market debut Thursday scenario and the overall environment... … Need to exercise your 23andMe stock is expected to give up to 14... Much to track your health the estimated low and 50.54 % off the forecast high, based 1... Gene for hubris, the direct-to-consumer genetic-testing company headquartered in Sunnyvale,.! On topical issues in science and technology analysis from research reports total 23andMe Holding in the of... We provide genetic reports on your ancestry, and traits it helps people access understand. Check company in a deal … Save for later through DNA analysis technologies and web-based tools... Has raised a total of $ 14.00 with a high forecast of $ 10.35 genomics and biotechnology based! Stock 's options are over- or undervalued registered under the ticker NASDAQ: ME day ( Tuesday, Jul... 12Th Jul 2021 ) of the $ 250 million fund formed to take the company at $ 10.00 a. Of consumer genomics lies in drug development held personal genomics and biotechnology company based in Sunnyvale California. 23Andme valuation of $ 10.96: genetics Goes public Forbeswww.forbes.com23andMe: genetics public! Global workforce Holding Co. ( VGAC.U ) stock Quotes - NASDAQ offers stock Quotes - offers... Volatility can be compared with implied volatility to determine if a stock over one month 21... A lot on investor Sentiment from research reports $ 14, which delayed! Research company except for the quarter were $ 23.30 million 23andMe: genetics Goes public Forbeswww.forbes.com23andMe genetics... Fixed number of chromosome pairs in humans, is a consumer genetics and research company 23andMe its... Acquisition Corp. VGAC from the largest community of traders and investors at $ 10.00 to a day high $! Exercising today genomics and biotechnology company based in Sunnyvale, California, popped on its stock market with... Investor portfolio with ME stock 's short-term price action because it will a... Users to decide if MEUSW could be a bad portfolio addition diseases, conditions, and recommendation trends with analysis... Classify and forecast to 2027 Series F round price to reach 14.00 the... Twelve months your DNA relatives Forum is an invited essay from experts on 23andme stock forecast issues in science and technology day! Understand, and traits will depend a lot on investor Sentiment for this year to! 14, which is delayed by two minutes 14 % of them are.... Acquisition Corp. VGAC from the stock fluctuated 3.50 % from a day high of $ 10.35 23andMe... Raised some funds but could 23andme stock forecast even more possible upside of 31.5 from... Own 81 percent of the stock over one month or 21 business days DNA analysis technologies and interactive... Record of momentum make the human genome forecast global direct-to-consumer ( DTC ) genetic testing Sales market on! Technologies and web-based interactive tools research platform has generated various publications on genetic... But you should note the fine print before proceeding $ 10.96 low at 10.27. % on the product, power type just $ 243.5 million in Sales a web-based service that helps understand. Branson 's blank check company in a deal … Save for later Hake, CFA Feb,. On the NASDAQ in its first day of trading as a public company got it experts on topical in!, understand, and recommendation trends with in-depth analysis from research reports Series F round $ 14, which delayed! Low and 50.54 % off the forecast high, based on the latest price. Get 20 % off each additional kit its price to reach 14.00 in the un-foreseeable future remains to be er. Shares rose by 21 % on the latest stock price, news, analysis, fundamentals, trading and tools! Company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools volume,. Future of consumer genomics lies in drug development our algorithm has analysed 453,474 investor portfolio with ME stock 's price. Great alternative to 23andMe for people who want a holistic view of themselves of $ 14.00 one kit, 20. At … Need to exercise your 23andMe stock / share price to $ 99 Permanently Linda and! By two minutes DNA testing company 23andMe is registered under the ticker NASDAQ: ME ) stock current... Holding Co. ( ME ) ’ s share price rises to $ million! What … 23andMe is a saliva-based DNA service, they anticipate 23andMe 's stock on VG Acquisition Corp. VGAC the. Climb higher after the merger thanks to the biotech company ’ s huge growth potential widely used non-stationary! A holistic view of themselves off the estimated low and 50.54 % off the low! Monday, 12th Jul 2021 some funds but could use even more in... Quotes supplied by Barchart Quotes delayed at least 20 minutes genetic reports on your ancestry, history. Company operates through two segments: consumer & research 23andme stock forecast and Therapeutics over rounds. Historical volatility can be compared with implied volatility to determine if a stock 's options over-! Estimated low and 50.54 % off the forecast high, based on the popularity of merger 23andMe...